GDF15 and metabolic dysfunction-associated steatohepatitis: This is further reinforced by Kim K.H. et al. (2018) who recently showed that GDF15 deficient mice are prone to increased deposition of lipid in liver and development of symptoms resembling nonalcoholic fatty liver disease (NASH/NAFLD) whereas GDF15 overexpressing transgenic mice were resistant.